Literature DB >> 22528831

Antipsychotic induced alteration of growth and proteome of rat neural stem cells.

Eakhlas Uddin Ahmed1, Selina Ahmed, Wataru Ukai, Izuru Matsumoto, Andrew Kemp, Iain S McGregor, Mohammed Abul Kashem.   

Abstract

Neural stem cells (NSCs) play a crucial role in the development and maturation of the central nervous system and therefore have the potential to target by therapeutic agents for a wide variety of diseases including neurodegenerative and neuropsychiatric illnesses. It has been suggested that antipsychotic drugs have significant effects on NSC activities. However, the molecular mechanisms underlying antipsychotic-induced changes of NSC activities, particularly growth and protein expression, are largely unknown. NSCs were treated with either haloperidol (HD; 3 μM), risperidone (RS; 3 μM) or vehicle (DMSO) for 96 h. Protein expression profiles were studied through a proteomics approach. RS promoted and HD inhibited the growth of NSCs. Proteomics analysis revealed that 15 protein spots identified as 12 unique proteins in HD-, and 20 protein spots identified as 14 proteins in RS-treated groups, were differentially expressed relative to control. When these identified proteins were compared between the two drug-treated groups, 2 proteins overlapped leaving 10 HD-specific and 12 RS-specific proteins. Further comparison of the overlapped altered proteins of 96 h treatment with the neuroleptics-induced overlapped proteins at 24 h time interval (Kashem et al. [40] in Neurochem Int 55:558-565, 2009) suggested that overlapping altered proteins expression at 24 h was decreased (17 proteins i.e. 53 % of total expressed proteins) with the increase of time (96 h) (2 proteins; 8 % of total expressed proteins). This result indicated that at early stage both drugs showed common mode of action but the action was opposite to each other while administration was prolonged. The opposite morphological pattern of cellular growth at 96 h has been associated with dominant expression of oxidative stress and apoptosis cascades in HD, and activation of growth regulating metabolic pathways in RS treated cells. These results may explain RS induced repairing of neural damage caused by a wide variety of neural diseases including schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528831     DOI: 10.1007/s11064-012-0768-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  87 in total

1.  Mechanism study of Aconitum-induced neurotoxicity in PC12 cells: involvement of dopamine release and oxidative damage.

Authors:  Yinglan Zhao; Qian Bu; Yan Zhou; Lei Lv; Guangyan Yan; Bo Chen; Li Wang; Xiaobo Cen
Journal:  Neurotoxicology       Date:  2010-06-30       Impact factor: 4.294

2.  Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex.

Authors:  Vivek Verma; Ee Peng Lim; Siew Ping Han; Rajini Nagarajah; Gavin S Dawe
Journal:  Neurosci Res       Date:  2006-10-05       Impact factor: 3.304

3.  Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.

Authors:  Anilkumar Pillai; Vinay Parikh; Alvin V Terry; Sahebarao P Mahadik
Journal:  J Psychiatr Res       Date:  2006-03-27       Impact factor: 4.791

4.  Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia.

Authors:  P M Thompson; A C Sower; N I Perrone-Bizzozero
Journal:  Biol Psychiatry       Date:  1998-02-15       Impact factor: 13.382

5.  Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses.

Authors:  Richard D McCurdy; François Féron; Chris Perry; David C Chant; Duncan McLean; Nick Matigian; Nicholas K Hayward; John J McGrath; Alan Mackay-Sim
Journal:  Schizophr Res       Date:  2006-01-06       Impact factor: 4.939

6.  Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons.

Authors:  H M Critchlow; P R Maycox; J N Skepper; O Krylova
Journal:  Mol Cell Neurosci       Date:  2006-07-17       Impact factor: 4.314

7.  In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.

Authors:  George Bartzokis; Po H Lu; Stephanie B Stewart; Bolanle Oluwadara; Andrew J Lucas; Joanna Pantages; Erika Pratt; Jonathan E Sherin; Lori L Altshuler; Jim Mintz; Michael J Gitlin; Kenneth L Subotnik; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-17       Impact factor: 4.939

8.  [Effect of acylation stimulating protein on the perilipin and adipophilin expression during 3T3-L1 preadipocyte differentiation.].

Authors:  Jing Wu; Hui-Ling Lu; Xiu-Fen Hu; Xiao-Yan Liang; Han-Hua Lin; Hong-Wei Wang; Xiao-Wei Fan
Journal:  Sheng Li Xue Bao       Date:  2009-02-25

9.  Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.

Authors:  Benedicto Crespo-Facorro; Roberto Roiz-Santiáñez; Rocío Pérez-Iglesias; José M Pelayo-Terán; José M Rodríguez-Sánchez; Diana Tordesillas-Gutiérrez; MariLuz Ramírez; Obdulia Martínez; Agustin Gutiérrez; Enrique Marco de Lucas; José L Vázquez-Barquero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-10-07       Impact factor: 5.067

10.  Proteomic analysis demonstrates adolescent vulnerability to lasting hippocampal changes following chronic alcohol consumption.

Authors:  Garth A Hargreaves; Heidi Quinn; Mohammed A Kashem; Izuru Matsumoto; Iain S McGregor
Journal:  Alcohol Clin Exp Res       Date:  2008-10-18       Impact factor: 3.455

View more
  7 in total

Review 1.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

2.  Neuroadaptations in the striatal proteome of the rat following prolonged excessive sucrose intake.

Authors:  Selina Ahmed; Mohammed Abul Kashem; Ranjana Sarker; Eakhlas U Ahmed; Garth A Hargreaves; Iain S McGregor
Journal:  Neurochem Res       Date:  2014-03-15       Impact factor: 3.996

3.  Exposure of Rat Neural Stem Cells to Ethanol Affects Cell Numbers and Alters Expression of 28 Proteins.

Authors:  Mohammed A Kashem; Nilufa Sultana; Vladimir J Balcar
Journal:  Neurochem Res       Date:  2018-07-24       Impact factor: 3.996

4.  Proteome Analysis of PC12 Cells Reveals Alterations in Translation Regulation and Actin Signaling Induced by Clozapine.

Authors:  Urszula Jankowska; Bozena Skupien-Rabian; Bianka Swiderska; Gabriela Prus; Marta Dziedzicka-Wasylewska; Sylwia Kedracka-Krok
Journal:  Neurochem Res       Date:  2021-05-23       Impact factor: 3.996

5.  Proteomic Analysis of Plasma Markers in Patients Maintained on Antipsychotics: Comparison to Patients Off Antipsychotics and Normal Controls.

Authors:  Rudolf Engelke; Sami Ouanes; Suhaila Ghuloum; Rifka Chamali; Nancy Kiwan; Hina Sarwath; Frank Schmidt; Karsten Suhre; Hassen Al-Amin
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 4.157

6.  Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of "paradoxical" antidepressant responses in young persons.

Authors:  Emily A Karanges; Mohammed A Kashem; Ranjana Sarker; Eakhlas U Ahmed; Selina Ahmed; Petra S Van Nieuwenhuijzen; Andrew H Kemp; Iain S McGregor
Journal:  Front Pharmacol       Date:  2013-07-08       Impact factor: 5.810

7.  Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes.

Authors:  Juliana S Cassoli; Keiko Iwata; Johann Steiner; Paul C Guest; Christoph W Turck; Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  Front Cell Neurosci       Date:  2016-03-03       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.